Patents by Inventor Masatoshi ARIMURA

Masatoshi ARIMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mirabegron-containing tablet, method for producing mirabegron-containing pharmaceutical preparation, and method for producing mirabegron-containing granulated product
    Patent number: 10925861
    Abstract: To provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Also, to provide a mirabegron-containing pharmaceutical preparation that can maintain the purity of mirabegron while preventing the generation of related substances at the time of storage, a method for producing a mirabegron-containing pharmaceutical preparation, and a method for producing a mirabegron-containing granulated product. According to an embodiment of the present invention, there is provided a mirabegron-containing pharmaceutical preparation containing mirabegron, hypromellose, and polyvinylpyrrolidone. The mirabegron-containing pharmaceutical preparation may contain a spray-dried granulated product containing the mirabegron, the hypromellose, and the polyvinylpyrrolidone.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: February 23, 2021
    Assignee: SAWAI PHARMACEUTICAL CO., LTD.
    Inventors: Toshihiro Yanagi, Kenji Nozawa, Kaori Umemura, Masatoshi Arimura, Akiko Takada
  • MIRABEGRON-CONTAINING TABLET, METHOD FOR PRODUCING MIRABEGRON-CONTAINING PHARMACEUTICAL PREPARATION, AND METHOD FOR PRODUCING MIRABEGRON-CONTAINING GRANULATED PRODUCT
    Publication number: 20180185339
    Abstract: To provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Also, to provide a mirabegron-containing pharmaceutical preparation that can maintain the purity of mirabegron while preventing the generation of related substances at the time of storage, a method for producing a mirabegron-containing pharmaceutical preparation, and a method for producing a mirabegron-containing granulated product. According to an embodiment of the present invention, there is provided a mirabegron-containing pharmaceutical preparation containing mirabegron, hypromellose, and polyvinylpyrrolidone. The mirabegron-containing pharmaceutical preparation may contain a spray-dried granulated product containing the mirabegron, the hypromellose, and the polyvinylpyrrolidone.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Inventors: Toshihiro YANAGI, Kenji NOZAWA, Kaori UMEMURA, Masatoshi ARIMURA, Akiko TAKADA